Skip to Main Content
Back to News

Insider Purchase: Director at $AUPH Buys 1,000,000 Shares

Automated

KEVIN TANG, a director at $AUPH, bought 1,000,000 shares of the company on 08-01-2025 for an estimated $10,120,000. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 10.0%. Following this trade, they now own 11,029,500 shares of this class of $AUPH stock.

$AUPH Insider Trading Activity

$AUPH insiders have traded $AUPH stock on the open market 14 times in the past 6 months. Of those trades, 3 have been purchases and 11 have been sales.

Here’s a breakdown of recent trading of $AUPH stock by insiders over the last 6 months:

  • KEVIN TANG has made 3 purchases buying 1,300,000 shares for an estimated $13,590,000 and 0 sales.
  • PETER GREENLEAF (Chief Executive Officer) has made 0 purchases and 2 sales selling 360,540 shares for an estimated $2,871,124.
  • MATTHEW MAXWELL DONLEY (Chief Operating Officer) has made 0 purchases and 2 sales selling 124,893 shares for an estimated $994,424.
  • STEPHEN P. ROBERTSON (EVP, General Counsel) has made 0 purchases and 2 sales selling 122,479 shares for an estimated $975,223.
  • JOSEPH M MILLER (Chief Financial Officer) has made 0 purchases and 2 sales selling 118,013 shares for an estimated $939,611.
  • GREG KEENAN (Chief Medical Officer) has made 0 purchases and 3 sales selling 40,544 shares for an estimated $376,262.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$AUPH Hedge Fund Activity

We have seen 100 institutional investors add shares of $AUPH stock to their portfolio, and 82 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$AUPH Analyst Ratings

Wall Street analysts have issued reports on $AUPH in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • RBC Capital issued a "Outperform" rating on 08/01/2025
  • HC Wainwright & Co. issued a "Buy" rating on 07/30/2025

To track analyst ratings and price targets for $AUPH, check out Quiver Quantitative's $AUPH forecast page.

$AUPH Price Targets

Multiple analysts have issued price targets for $AUPH recently. We have seen 2 analysts offer price targets for $AUPH in the last 6 months, with a median target of $13.0.

Here are some recent targets:

  • Douglas Miehm from RBC Capital set a target price of $9.0 on 08/01/2025
  • Arthur He from HC Wainwright & Co. set a target price of $17.0 on 07/30/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles